Qualitative secondary analysis of a pilot RCT of subcutaneous lidocaine vs placebo for neuropathic cancer pain: 7 of 17 randomised participants and 1 carer were interviewed; themes were hope and purpose, multiple influences on perceived effect, and pain's pervasive impact.
Secondary analysisn = 8
Lee et al. Feasibility and acceptability of "LiCPain" pilot randomised controlled trial of continuous subcutaneous infusion of lidocaine or placebo for people with neuropathic cancer pain: a qualitative study of patient and carer perceptions and experiences